TP53 and cancer: Compelling evidence of p53/SLC7A11 regulatory circuitry that is active in both normal and cancer cells has been provided by Jiang and colleagues, who demonstrated that the SLC7A11 gene is a target for p53-mediated transcriptional repression [118].